Intravenous fish oil in adult intensive care unit patients

World Review of Nutrition and Dietetics

Volumn 112, Issue , 2015, Pages 127-140

  Heller, Axel R ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BORAGINACEAE;

ANTIOXIDANT; BORAGE OIL; FISH OIL; GAMMA LINOLENIC ACID; LIPID EMULSION; OMEGA 3 FATTY ACID; VEGETABLE OIL;

ADULT; CRITICAL ILLNESS; ENTERIC FEEDING; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; META ANALYSIS (TOPIC); RESPIRATORY DISTRESS SYNDROME, ADULT;

ADMINISTRATION, INTRAVENOUS; ADULT; ANTIOXIDANTS; CRITICAL ILLNESS; ENTERAL NUTRITION; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, OMEGA-3; FISH OILS; GAMMA-LINOLENIC ACID; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; META-ANALYSIS AS TOPIC; PLANT OILS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84918790453     PISSN: 00842230     EISSN: 16623975     Source Type: Book Series    
DOI: 10.1159/000365607     Document Type: Article

References (62)

1. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL: Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;35:1244-1250.
2. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013;39:165-228.
3. Calder PC: Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol 2013;75:645-662.
4. Heller AR, Rössler S, Litz RJ, Stehr SN, Heller SC, Koch R, et al: Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006;34:972-979.
5. Pradelli L, Eandi M, Povero M, Mayer K, Muscaritoli M, Heller AR, et al: Cost-effectiveness of omega-3 fatty acid supplements in parenteral nutrition therapy in hospitals: A discrete event simulation model. Clin Nutr 2013; DOI: 10.1016/j.clnu.2013. 11.016.
6. Heller AR, Theilen HJ, Koch T: Fish or chips? News Physiol Sci 2003;18:50-54.
7. Calder PC: Mechanisms of action of (n-3) fatty acids. J Nutr 2012;142:592S-599S.
8. Heller A, Koch T, Schmeck J, Van AK: Lipid mediators in inflammatory disorders. Drugs 1998;55:487-496.
9. Serhan CN, Chiang N: Resolution phase lipid mediators of inflammation: agonists of resolution. Curr Opin Pharmacol 2013;13:632-640.
10. Breil I, Koch T, Heller A, Schlotzer E, Grunert A, Van AK, et al: Alteration of n-3 fatty acid composition in lung tissue after short-term infusion of fish oil emulsion attenuates inflammatory vascular reaction. Crit Care Med 1996;24:1893-1902.
11. Koch T, Heller A, Breil I, Van Ackern K, Neuhof H: Alterations of pulmonary capillary filtration and leukotriene synthesis due to infusion of a lipid emulsion enriched with omega 3 fatty acids. Clin Intens Care 1995;6:112-120.
12. Berger MM, Delodder F, Liaudet L, Tozzi P, Schlaepfer J, Chiolero RL, et al: Three short perioperative infusions of n-3 PUFAs reduce systemic inflammation induced by cardiopulmonary bypass surgery: a randomized controlled trial. Am J Clin Nutr 2013;97:246-254.
13. Heller A, Denz A, Neidel J, Konopke R, Gottschlich B, Seifert S, et al: Effects of a metabolic optimized fasttrack concept (MOFA). Infection 2011;39(suppl II):S126.
14. Manzanares W, Dhaliwal R, Jurewitsch B, Stapleton RD, Jeejeebhoy KN, Heyland DK: Parenteral fish oil lipid emulsions in the critically ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 2014;38:20-28.
15. Palmer AJ, Ho CK, Ajibola O, Avenell A: The role of omega-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis. Crit Care Med 2013;41:307-316.
16. Pradelli L, Mayer K, Muscaritoli M, Heller AR: n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis. Crit Care 2012;16:R184.
17. Li NN, Zhou Y, Qin XP, Chen Y, He D, Feng JY, et al: Does intravenous fish oil benefit patients postsurgery? A meta-analysis of randomised controlled trials. Clin Nutr 2014;33:226-239.
18. Calder PC, Deckelbaum RJ: Intravenous fish oil in hospitalized adult patients: reviewing the reviews. Curr Opin Clin Nutr Metab Care 2013;16:119-123.
19. Calder PC: Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011;668(suppl 1):S50-S58.
20. Barbosa VM, Miles EA, Calhau C, Lafuente E, Calder PC: Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical outcomes in septic patients: a randomized, controlled clinical trial. Crit Care 2010;14:R5.
21. Wang X, Li W, Li N, Li J: Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JPEN J Parenter Enteral Nutr 2008;32:236-241.
22. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN: Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001;2:612-619.
23. Wendel M, Paul R, Heller AR: Lipoproteins in inflammation and sepsis. II. Clinical aspects. Intensive Care Med 2007;33:25-35.
24. Wendel M, Heller AR: Anticancer actions of omega-3 fatty acids - current state and future perspectives. Anticancer Agents Med Chem 2009;9:457-470.
25. Heller AR, Rössel T, Gottschlich B, Tiebel O, Menschikowski M, Litz RJ, et al: Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer 2004;111:611-616.
26. Arita M, Bianchini F, Aliberti J, Sher A, Chiang N, Hong S, et al: Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005;201:713-722.
27. Molvig J, Pociot F, Worsaae H, Wogensen LD, Baek L, Christensen P, et al: Dietary supplementation with omega-3-polyunsaturated fatty acids decreases mononuclear cell proliferation and interleukin-1 beta content but not monokine secretion in healthy and insulin-dependent diabetic individuals. Scand J Immunol 1991;34:399-410.
28. Palombo JD, De Michele SJ, Boyce PJ, Lydon EE, Liu JW, Huang YS, et al: Effect of short-term enteral feeding with eicosapentaenoic and gamma-linolenic acids on alveolar macrophage eicosanoid synthesis and bactericidal function in rats. Crit Care Med 1999;27:1908-1915.
29. Mayer K, Fegbeutel C, Hattar K, Sibelius U, Kramer HJ, Heuer KU, et al: Omega-3 vs omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. Intensive Care Med 2003;29:1472-1481.
30. Mayer K, Gokorsch S, Fegbeutel C, Hattar K, Rosseau S, Walmrath D, et al: Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003;167:1321-1328.
31. Canadian Clinical Practice Guideline Committee: 9.2 Composition of parenteral nutrition: type of lipids. 2013. http://www.criticalcarenutrition.com/docs/cpgs2012/9.2.pdf (accessed Dec. 23, 2013).
32. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al: Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012;307:2526-2533.
33. Kelbel I, Koch T, Prechtl A, Heller A, Schlotzer E, Schiefer G, et al: Effects of parenteral application of fish oil versus soy oil emulsions on bacterial clearance functions. Infusionsther Transfusionsmed 1999;26:226-232.
34. Pscheidl E, Schywalsky M, Tschaikowsky K, Boke-Prols T: Fish oil-supplemented parenteral diets normalize splanchnic blood flow and improve killing of translocated bacteria in a low-dose endotoxin rat model. Crit Care Med 2000;28:1489-1496.
35. Mayer K, Grimm H, Grimminger F, Seeger W: Parenteral nutrition with n-3 lipids in sepsis. Br J Nutr 2002;87(suppl 1):S69-S75.
36. Elamin E, Miller A, Ziad S: Immune enteral nutrition can improve outcomes in medical-surgical patients with ARDS: a prospective randomized controlled trial. J Nutr Disorders Ther 2012;2:109.
37. Theilla M, Schwartz B, Zimra Y, Shapiro H, Anbar R, Rabizadeh E, et al: Enteral n-3 fatty acids and micronutrients enhance percentage of positive neutrophil and lymphocyte adhesion molecules: a potential mediator of pressure ulcer healing in critically ill patients. Br J Nutr 2012;107:1056-1061.
38. Gadek JE, De Michele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, et al: Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med 1999;27:1409-1420.
39. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J: Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 2006;34:1033-1038.
40. Pontes-Arruda A, Aragao AM, Albuquerque JD: Effects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med 2006;34:2325-2333.
41. Grau-Carmona T, Moran-Garcia V, Garcia-De-Lorenzo A, Heras-De-La-Calle G, Quesada-Bellver B, Lopez-Martinez J, et al: Effect of an enteral diet enriched with eicosapentaenoic acid, gamma-linolenic acid and anti-oxidants on the outcome of mechanically ventilated, critically ill, septic patients. Clin Nutr 2011;30:578-584.
42. Canadian Clinical Practice Guideline Committee: 4.1b (i) Composition of enteral nutrition: fish oils, borage oils and antioxidants. 2013. http://www.criticalcarenutrition.com/docs/cpgs2012/4.1b (i).pdf (accessed Dec. 23, 2013).
43. Rice TW, Wheeler AP, Thompson BT, De Boisblanc BP, Steingrub J, Rock P: Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 2011;306:1574-1581.
44. Felbinger TW, Weigand MA, Mayer K: Supplementation in acute lung injury. JAMA 2012;307:144-146.
45. Friesecke S, Lotze C, Kohler J, Heinrich A, Felix SB, Abel P: Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial. Intensive Care Med 2008;34:1411-1420.
46. Wichmann MW, Thul P, Czarnetzki HD, Morlion BJ, Kemen M, Jauch KW: Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): data from a prospective, randomized, multicenter trial. Crit Care Med 2007;35:700-706.
47. Grecu I, Mirea L, Grintescu I: Parenteral fish oil supplementation in patients with abdominal sepsis. Clin Nutr 2003;22(suppl 1):23.
48. Ignatenko O, Yaroshetskiy A, Masolitin S, Protsenko D, Gelfand B: Fish oil treatment in severe trauma patients. Intensive Care Med 2010;36:S316.
49. Leiderman I, Malkova O, Levit A: Omega 3 enriched lipid emulsion decreases APACHE II and SOFA scores values in abdominal sepsis patients. Clin Nutr Suppl 2010;5:30.
50. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al: The PRISMA statement for reporting systematic reviews and metaanalyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009;6:e1000100.
51. Petticrew M, Kennedy SC: Detecting the effects of thromboprophylaxis: the case of the rogue reviews. BMJ 1997;315:665-668.
52. Heller AR, Fischer S, Rössel T, Geiger S, Siegert G, Ragaller M, et al: Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery. Br J Nutr 2002;87(suppl 1):S95-S101.
53. Wendel M, Rössel T, Bergmann S, Otto S, Ragaller M, Zimmermann T, et al: Impact of total parenteral nutrition including omega-3 fatty acids on the regulation of plasma lipoproteins and glycemic control after major abdominal surgery. e-ESPEN 2007;2:e103-e110.
54. Altman DG, Bland JM: Absence of evidence is not evidence of absence. BMJ 1995;311:485.
55. Chen B, Zhou Y, Yang P, Wan HW, Wu XT: Safety and efficacy of fish oil-enriched parenteral nutrition regimen on postoperative patients undergoing major abdominal surgery: a meta-analysis of randomized controlled trials. JPEN J Parenter Enteral Nutr 2010;34:387-394.
56. Gupta A, Govil D, Bhatnagar S, Gupta S, Goyal J, Patel S, et al: Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury. Indian J Crit Care Med 2011;15:108-113.
57. Wang X, Li W, Zhang F, Pan L, Li N, Li J: Fish oilsupplemented parenteral nutrition in severe acute pancreatitis patients and effects on immune function and infectious risk: a randomized controlled trial. Inflammation 2009;32:304-309.
58. Sabater J, Masclans JR, Sacanell J, Chacon P, Sabin P, Planas M: Effects of an omega-3 fatty acid-enriched lipid emulsion on eicosanoid synthesis in acute respiratory distress syndrome (ARDS): a prospective, randomized, double-blind, parallel group study. Nutr Metab (Lond) 2011;8:22.
59. Berger MM, Tappy L, Revelly JP, Koletzko BV, Gepert J, Corpataux JM, et al: Fish oil after abdominal aorta aneurysm surgery. Eur J Clin Nutr 2008;62:1116-1122.
60. Weiss G, Meyer F, Matthies B, Pross M, Koenig W, Lippert H: Immunomodulation by perioperative administration of n-3 fatty acids. Br J Nutr 2002;87(suppl 1):S89-S94.
61. Wachtler P, Konig W, Senkal M, Kemen M, Koller M: Influence of a total parenteral nutrition enriched with omega-3 fatty acids on leukotriene synthesis of peripheral leukocytes and systemic cytokine levels in patients with major surgery. J Trauma 1997;42:191-198.
62. Khor BS, Liaw SJ, Shih HC, Wang LS: Randomized, double blind, placebo-controlled trial of fish-oilbased lipid emulsion infusion for treatment of critically ill patients with severe sepsis. Asian J Surg 2011;34:1-10.